Evaluation of Wearable Digital Devices in a Phase I Clinical Trial

• Ngā kaituhi matua: Elena S. Izmailova (Author), Ian L. McLean (Author), Gaurav Bhatia (Author), Greg Hather (Author), Matthew Cantor (Author), David Merberg (Author), Eric D. Perakslis (Author), Christopher Benko (Author), John A. Wagner (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2019-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

We assessed the performance of two US Food and Drug Administration (FDA) 510(k)‐cleared wearable digital devices and the operational feasibility of deploying them to augment data collection in a 10‐day residential phase I clinical trial. The Phillips Actiwatch Spectrum Pro (Actiwatch) was used to as...